(Q40237944)

18 September 2017

The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich (English)

1 reference

18 September 2017

1 reference

Wimmer CD

1

1 reference

18 September 2017

Rentsch M

2

1 reference

18 September 2017

Crispin A

3

1 reference

18 September 2017

Illner WD

4

1 reference

18 September 2017

Arbogast H

5

1 reference

18 September 2017

Graeb C

6

1 reference

18 September 2017

Jauch KW

7

1 reference

18 September 2017

Guba M

8

1 reference

18 September 2017

language of work or name

English

0 references

publication date

28 February 2007

1 reference

18 September 2017

1 reference

18 September 2017

71

1 reference

18 September 2017

12

1 reference

18 September 2017

1271-1278

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002154

18 September 2017

0 references

cites work

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Recurrence of cancer after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Non-melanoma skin cancer risk in the Queensland renal transplant population.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Skin cancers after organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

The pleiotropic effects of Kaposi's sarcoma herpesvirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Surveillance against tumors--is it mainly immunological?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Azathioprine and UVA light generate mutagenic oxidative DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Cancer after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002154

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002154

1 reference

18 September 2017

1 reference